Shake Shack Inc. (“Shake Shack” or the “Company”) today announced the
pricing of its initial public offering of 5,000,000 shares of its Class
A common stock at a public offering price of $21.00 per share.
Aurinia Pharmaceuticals, Inc., (NASDAQ: AUPH / TSX: AUP) today announced
that its President and Chief Executive Officer Stephen Zaruby will
present a corporate overview of the company at the BIO CEO Investor
Conference, taking place February 9th-10th in New York at the
Calpine Corporation (NYSE:CPN) today announced the pricing of
$650,000,000 in aggregate principal amount of its 5.500% Senior
Unsecured Notes due 2024 pursuant to the Company’s shelf registration
statement filed with the Securities and Exchange Commission.
Intercept Pharmaceuticals Inc. (ICPT) said the U.S. Food and Drug Administration granted the company's investigational treatment for a liver disease breakthrough-therapy status, providing access to a potentially faster regulatory-review process.
Sign-up for IMPORTANT ANNOUNCEMENT: Wolf Haldenstein Adler Freeman & Herz LLP Announces That a Federal Securities Class Action Has Been Filed Against ChannelAdvisor Corporation -- ECOM investment picks
(FROM THE WALL STREET JOURNAL 1/30/15)
By Julie Steinberg
Ally Financial Inc.'s chief executive Thursday reacted angrily to General Motors Co.'s decision to squeeze the lender out of a lucrative leasing business and vowed to overcome getting jilted by the firm's former parent.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.